nicardipine has been researched along with Hypertension, Portal in 4 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Portal hypertension was induced in rats by partial portal vein ligation." | 1.29 | Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats. ( Kawasaki, T; Nagasawa, M; Yoshimi, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Pagán, JC | 1 |
| Feu, F | 1 |
| Luca, A | 1 |
| Fernández, M | 1 |
| Pizcueta, P | 1 |
| Bosch, J | 1 |
| Rodés, J | 1 |
| Iwao, T | 2 |
| Toyonaga, A | 2 |
| Ikegami, M | 2 |
| Oho, K | 2 |
| Sumino, M | 2 |
| Sakaki, M | 2 |
| Shigemori, H | 1 |
| Nakayama, M | 1 |
| Sasaki, E | 1 |
| Tanikawa, K | 1 |
| Nagasawa, M | 1 |
| Kawasaki, T | 1 |
| Yoshimi, T | 1 |
| Sugawara, H | 1 |
| Takagi, K | 1 |
| Ohkubo, K | 1 |
| Inoue, R | 1 |
2 trials available for nicardipine and Hypertension, Portal
| Article | Year |
|---|---|
Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
Topics: Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Indocyanine Green; Liver Circulation; Live | 1994 |
Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
Topics: Aged; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Liver; Liver Ci | 1993 |
2 other studies available for nicardipine and Hypertension, Portal
| Article | Year |
|---|---|
Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats.
Topics: Animals; Calcium Channel Blockers; Consciousness; Diltiazem; Hemodynamics; Hypertension, Portal; Liv | 1996 |
Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Infusions, Intravenous; Liver; Live | 1992 |